AXQ Capital’s AbbVie ABBV Stock Holding History

AXQ Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$613K	Buy	+2,437	New	+$524K	0.07%	421
2026 Q1	–	Sell	-2,469	Closed	-$564K	–	975
2025 Q4	$564K	Buy	2,469 +1,336	+118%	+$304K	0.13%	266
2025 Q3	$262K	Sell	1,133 -8,845	-89%	-$1.8M	0.1%	360
2025 Q2	$1.85M	Buy	9,978 +1,762	+21%	+$327K	0.6%	16
2025 Q1	$1.72M	Buy	+8,216	New	+$1.6M	0.69%	13
2024 Q4	–	Sell	-9,425	Closed	-$1.86M	–	413
2024 Q3	$1.86M	Buy	+9,425	New	+$1.76M	0.56%	23
2024 Q2	–	Sell	-3,700	Closed	-$674K	–	425
2024 Q1	$674K	Buy	+3,700	New	+$638K	0.16%	224
2023 Q3	–	Sell	-2,900	Closed	-$391K	–	453
2023 Q2	$391K	Buy	+2,900	New	+$425K	0.48%	68
2023 Q1	–	Sell	-6,881	Closed	-$1.11M	–	469
2022 Q4	$1.11M	Buy	+6,881	New	+$1.06M	0.77%	22

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AXQ Capital's ABBV Position: Q2 2026 in Review

AXQ Capital opened a new position in AbbVie (ABBV) in Q2 2026: 2,437 shares worth $613K. The stake represents 0.07% of the portfolio and ranks #421 among its holdings. This is a return to the name: AXQ Capital previously reported a position in ABBV as recently as Q4 2025.

AXQ Capital first reported a position in ABBV in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.86M in Q3 2024. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

AXQ Capital held 2,437 shares of AbbVie worth $613K as of Q2 2026.
AbbVie was a new AXQ Capital position in Q2 2026.
AbbVie made up 0.07% of AXQ Capital's portfolio in Q2 2026, its #421 holding.
AXQ Capital first reported a position in AbbVie in Q4 2022 and has held it in 9 quarters since.
AXQ Capital's AbbVie position peaked at $1.86M in Q3 2024.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.